These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4110298)

  • 21. Studies on defined immunofluorescence in clinical immunopathology. II. Relationship of F/P ratios pf conjugates and staining properties in indirect immunofluorescence.
    Shu S; Deng JS; Vetter S; Beutner EH
    Ann N Y Acad Sci; 1975 Jun; 254():559-72. PubMed ID: 52325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibody analysis using immunofluorescent methods: quantification and standardization].
    Misgeld V
    Arch Dermatol Forsch; 1972; 244():291-7. PubMed ID: 4567625
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 24. Toward quantitation of excitation.
    Rygaard J; Olsen W
    Ann N Y Acad Sci; 1971 Jun; 177():410-3. PubMed ID: 4945673
    [No Abstract]   [Full Text] [Related]  

  • 25. Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors.
    Wiik A; Munthe E
    Immunology; 1972 Jul; 23(1):53-60. PubMed ID: 4114648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
    Landry M; Sams WM
    J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of specific antibody content of fluorescent conjugates by radioimmuno absorption.
    Bergquist NR; Norberg R
    J Immunol Methods; 1974 Aug; 5(3):275-82. PubMed ID: 4610057
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative studies of immunofluorescent staining. Relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors.
    Beutner EH; Sepulveda MR; Barnett EV
    Bull World Health Organ; 1968; 39(4):587-606. PubMed ID: 4179321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indirect immunofluorescent antinuclear antibody tests: comparison of sensitivity and specificity of different substrates.
    Cleymaet JE; Nakamura RM
    Am J Clin Pathol; 1972 Oct; 58(4):388-93. PubMed ID: 4565482
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-idiotypic auto-antibodies of anti-DNA antibodies in disseminated lupus erythematosus].
    Masmoudi H; Makni S; Bach JF
    Tunis Med; 1989 Oct; 67(10):617-20. PubMed ID: 2683279
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative studies on immunofluorescent staining. VII. Fractionation of conjugates by acid dialysis to reduce nonspecific staining.
    Binder WL; Beutner EH
    Int Arch Allergy Appl Immunol; 1980; 62(3):352-4. PubMed ID: 6156127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunofluorescence microphotometry for the detection of platelet antibodies. I. Standardization of the method.
    van Boxtel CJ; Engelfriet CP; Feltkamp TE
    Scand J Immunol; 1973; 2(3):217-29. PubMed ID: 4588995
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigations of liver biopsies for Australia antigen by immunofluorescent technique.
    Nielsen JO; Elling P
    Clin Exp Immunol; 1971 Dec; 9(6):699-705. PubMed ID: 4333813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinuclear factors, the antihumanglobulin consumption test, and Wassermann reaction in psoriatic arthritis.
    Zachariae H; Zachariae E
    Acta Rheumatol Scand; 1969; 15(1):62-6. PubMed ID: 4902688
    [No Abstract]   [Full Text] [Related]  

  • 35. Performance characteristics of the PolyTiter Immunofluorescent Titration system for determination of antinuclear antibody endpoint dilution.
    Flessland KA; Landicho HR; Borden KK; Prince HE
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):329-32. PubMed ID: 11874872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for anti-antibodies in positively stained immune complexes.
    Robinson JP; Schuffman SS
    Immunology; 1971 Jun; 20(6):883-93. PubMed ID: 4104283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunopathogenesis of lupus nephritis.
    Agnello V
    Adv Nephrol Necker Hosp; 1976; 6():119-36. PubMed ID: 65907
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on defined immunofluorescence in clinical immunopathology. III. Past progress, some new methods, and prospects for the future.
    Beutner EH; Deng JS; Shu S; Andersen P
    Ann N Y Acad Sci; 1975 Jun; 254():573-91. PubMed ID: 1101783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lab tests to pinpoint lupus.
    Healey LA
    Med Times; 1973 Jan; 101(1):97 passim. PubMed ID: 4119092
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative studies of immunofluorescent staining. IV. Indirect immunofluorescence blocking tests with anti-perinuclear factors of human and goat origin.
    Wick G; Beutner EH
    Immunology; 1970 Jun; 18(6):821-32. PubMed ID: 4913803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.